It looks like coverage on DKD is ramping up a bit in the UK on SGLT2 inhibitors as a preventative for progression to ESKD & tie this in to multiple articles quoting Napp Pharmaceuticals data on significant cracks in testing patients, not just in the UK, but Canada & the US as well (both countries have approved Invokana for CKD, CVD & these articles posted here some way back).
Hope everyone is having a great weekend & for all attending Mardi Gras, I hope you had a great night & feet & head not too sore this morning. We watched on TV as have some friends marching & appreciate all the amazing efforts, creativity & hard work that goes into costumes, floats & rehearsals. It’s great to see the spectacular end result.
PIQ Price at posting:
26.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
We watched on TV as have some friends marching & appreciate all the amazing efforts, creativity & hard work that goes into costumes, floats & rehearsals. It’s great to see the spectacular end result.
(20min delay)